Back
BioXcel Therapeutics Vs. 4D Molecular Therapeutics Industry Stock Comparison
Sell
17
BTAI
BioXcel Therapeutics
Last Price:
2.12
Seasonality Move:
-0.19%
Buy
55
FDMT
4D Molecular Therapeutics
Last Price:
26.24
Seasonality Move:
-18.33%
Sell
17
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy, Sell or Hold?
- The current BioXcel Therapeutics [BTAI] share price is $2.37. The Score for BTAI is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- BTAI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
4D Molecular Therapeutics (FDMT)
is a Buy
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $26.79. The Score for FDMT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- FDMT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BTAI Stock Price Chart
What is BioXcel Therapeutics's stock price today?
-
The BioXcel Therapeutics share price today is $2.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $26.79
The current trend is relatively stagnant and FDMT is experiencing slight buying pressure.
BTAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 36.35 | Sell |
| Chaikin Money Flow: | -631355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.52 - 2.78) | Sell |
| Bollinger Bands (100): | (2.56 - 3.26) | Sell |
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.59 | Sell |
| Relative Strength Index (14 RSI): | 51.86 | Buy |
| Chaikin Money Flow: | 70295 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.56 - 27.56) | Buy |
| Bollinger Bands (100): | (19.92 - 30.06) | Buy |
BTAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.54 | Sell |
| 20-day SMA: | 2.65 | Sell |
| 50-day SMA: | 2.79 | Sell |
| 200-day SMA: | 3.6 | Sell |
| 8-day EMA: | 2.53 | Sell |
| 20-day EMA: | 2.62 | Sell |
| 50-day EMA: | 2.77 | Sell |
| 200-day EMA: | 5.38 | Sell |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.38 | Buy |
| 20-day SMA: | 25.57 | Buy |
| 50-day SMA: | 28.29 | Sell |
| 200-day SMA: | 19.44 | Buy |
| 8-day EMA: | 25.9 | Buy |
| 20-day EMA: | 26.12 | Buy |
| 50-day EMA: | 26.52 | Buy |
| 200-day EMA: | 21.8 | Buy |
BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.16 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
BioXcel Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
4D Molecular Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||